Peter Schneider (University of California, San Francisco, USA) Tatsuya Nakama (Tokyo Bay Medical Center, Chiba, Japan), Yann Gouëffic (Hôpital Paris St Joseph, Paris, France) and Joakim Nordanstig (University of Gothenburg, Gothenburg, Sweden) discuss the latest developments in safety concerns around drug-coated technology use in the treatment of peripheral arterial disease (PAD).
Watch the full roundtable discussion here
